1,
Sponsors
National Research Council of Thailand (NRTC), Health Systems Research Institute, The College of Pharmacotherapy of Thailand
Conditions
1. Chronic kidney disease
2. Elderly
3. Pharmacokinetics
4. Cytochrome P 450
5. Drug transporter
1. Chronic kidney disease (CKD)
2. Elderly
3. Pharmacokinetics (PK)
4. Cytochrome P 450 (CYP450)
5. Drug transporter
6. OATP1B1
7. BCRPComplicated urinary tract infections with Escherichia coli or Klebsiella pneumoniae and ceftriaxone resistance
Amikacin,Muscle pain and osteoarthritis
Phase 1
Unknown Phase
CYP3A and drug transporters activity changes in Thai elderly with or without chronic kidney disease using a microdose cocktail
Active, not recruitingTCTR20180312002
Start: 2018-05-01Target: 60Updated: 2026-03-30
Efficacy and safety of amikacin versus ertapenem as definitive antibiotic therapy for complicated urinary tract infections caused by ceftriaxone resistance Escherichia coli or Klebsiella pneumoniae: an open-label, randomized, controlled, non-inferiority clinical trial
Active, not recruitingTCTR20190924001
Start: 2019-09-23Target: 102Updated: 2026-03-30